Clinical trials
Withdrawn Phase 1 Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bellicum Pharmaceuticals | 2 |
| City of Hope Medical Center | 2 |
| Celyad Oncology SA | 1 |
| Enzon Pharmaceuticals, Inc. | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Leland Metheny | 1 |
| Medigene AG | 1 |
| Montefiore Medical Center | 1 |
| Ossium Health, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 16 |
| Leukemia, Myeloid, Acute | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Leukemia | 4 |
| Lymphoma | 4 |
| Myeloproliferative Disorders | 4 |
| Hematologic Neoplasms | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Leukemia, Myelomonocytic, Chronic | 3 |
| Burkitt Lymphoma | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.